# Vagal Blocking for Obesity Control

> **NCT00555958** · NA · UNKNOWN · sponsor: **ReShape Lifesciences** · enrollment: 120 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DEVICE:** Active, implantable, intra-abdominal vagal blocking medical device

## Key facts

- **NCT ID:** NCT00555958
- **Lead sponsor:** ReShape Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-11
- **Primary completion:** 2011-09
- **Final completion:** 2014-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2012-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00555958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00555958, "Vagal Blocking for Obesity Control". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00555958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*